GPX4 and osteosarcoma: Therefore, to evaluate the sensitivity of human osteosarcoma to ferroptosis, we evaluated the induction and execution of this nonapoptotic cell death process in a panel of three human osteosarcoma (OS) cell lines: U2OS, MG63, and HOS, using the GPX4 specific inhibitor RSL3 as pro-ferroptotic inducer.